← All trials
NCT06959966
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 14, 2019
- Primary completion
- Dec 1, 2022
- Completion date
- Jan 31, 2023
- First posted
- May 7, 2025
- Last posted
- May 7, 2025
- Enrollment
- 18
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Taipei Medical UniversityLead sponsor
- Hi-Q Marine Biotech International, Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.